Notes - Consolidated Statement Of Comprehensive Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7329099

Concept 2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
Notes - Consolidated statement of comprehensive income
Notes - Consolidated single statement of comprehensive income
Notes regarding write-downs of inventories
Major components of selling, general and administrative expenses
Research and development expenses included in general and administrative expenses and manufacturing costs for period
Research and development expenses included in general and administrative expenses and manufacturing costs for period
1,469,000,000 JPY
1,353,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.